Article
Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study.
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia - 26 Jan 2024
Aoki Masaya, Miyata Ryo, Kamimura Go, Harada Takeda Aya, Suetsugu Takayuki, Mizuno Keiko, Ueda Kazuhiro
Abstract excerpt
PURPOSE: Tegafur-uracil (UFT) is the standard postoperative adjuvant therapy for stage IB lung adenocarcinoma (LUAD) in Japan. This study aimed to determine whether UFT is effective in stage IB LUAD with and without epidermal growth factor receptor (EGFR) mutations. METHODS: This retrospective study included 169 patients with stage IB LUAD who underwent complete resection at our department between 2010 and 2021....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.